{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:15:52Z","timestamp":1774685752058,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z191100006619014"],"award-info":[{"award-number":["Z191100006619014"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Decreased calcium-sensing receptor (CaSR) has been observed in hyperparathyroidism (HPT) without a known mechanism. The purpose of this study was to evaluate the expression of CaSR in primary (PHPT) and secondary (SHPT) subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Immunohistochemical (IHC) staining and quantitative real-time PCR (qRT-PCR) assay were used to measure the differences in expression of CaSR protein and gene in PHPT and SHPT human samples, compared to matched controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CaSR protein was differentially downregulated in SHPT and PHPT compared to normal parathyroid tissues (2.42\u2009\u00b1\u20090.5 vs. 3.2\u2009\u00b1\u20090.62, P\u2009&lt;\u20090.05; 1.8\u2009\u00b1\u20090.83 vs. 3.2\u2009\u00b1\u20090.62, P\u2009&lt;\u20090.05, respectively). Furthermore, SHPT tissues exhibited significantly higher levels of CaSR mRNA (0.29\u2009\u00b1\u20090.23 vs. 0.01\u2009\u00b1\u20090.12, P\u2009&lt;\u20090.05) and protein (2.42\u2009\u00b1\u20090.5 vs. 1.8\u2009\u00b1\u20090.83, P\u2009&lt;\u20090.05) than those in PHPT tissue samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Depressed CaSR expression was a critical pathological hallmark of HPT. We found a differential decline of CaSR, in terms of both mRNA and protein levels, in PHPT and SHPT human samples. We think that CaSR dysregulation occurred at the very beginning of disease onset in PHPT, while a similar pathological scenario appeared at the later stage of SHPT. Future studies should be directed to dissect the mechanistic involvement of CaSR in PHPT and SHPT in order to bring treatment precisions in HPT management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-023-01928-5","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T08:18:34Z","timestamp":1675844314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Primary and secondary hyperparathyroidism present different expressions of calcium-sensing receptor"],"prefix":"10.1186","volume":"23","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"1928_CR1","doi-asserted-by":"crossref","unstructured":"Dandurand K, Ali DS, Khan AA. Primary hyperparathyroidism: a narrative review of diagnosis and medical management. J Clin Med. 2021; 10(8).","DOI":"10.3390\/jcm10081604"},{"issue":"4","key":"1928_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ng0897-375","volume":"16","author":"C Heppner","year":"1997","unstructured":"Heppner C, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet. 1997;16(4):375\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"1928_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12022-018-9524-9","volume":"29","author":"AG Sengul","year":"2018","unstructured":"Sengul AG, et al. Clinical Impact of p27(Kip1) and CaSR expression on primary hyperparathyroidism. Endocr Pathol. 2018;29(3):250\u20138.","journal-title":"Endocr Pathol"},{"issue":"5","key":"1928_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1210\/me.2010-0277","volume":"25","author":"J Koh","year":"2011","unstructured":"Koh J, et al. Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor. Mol Endocrinol. 2011;25(5):867\u201376.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"1928_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13577-016-0143-9","volume":"29","author":"T Uchiyama","year":"2016","unstructured":"Uchiyama T, et al. Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet. Hum Cell. 2016;29(4):155\u201361.","journal-title":"Hum Cell"},{"issue":"12","key":"1928_CR6","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1210\/endo.141.12.7849","volume":"141","author":"JL Sanders","year":"2000","unstructured":"Sanders JL, et al. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology. 2000;141(12):4357\u201364.","journal-title":"Endocrinology"},{"issue":"3","key":"1928_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/138920109787847484","volume":"10","author":"SC Brennan","year":"2009","unstructured":"Brennan SC, Conigrave AD. Regulation of cellular signal transduction pathways by the extracellular calcium-sensing receptor. Curr Pharm Biotechnol. 2009;10(3):270\u201381.","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"1928_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","volume":"55","author":"AJ Brown","year":"1999","unstructured":"Brown AJ, et al. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int. 1999;55(4):1284\u201392.","journal-title":"Kidney Int"},{"issue":"12","key":"1928_CR9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1359\/jbmr.2002.17.12.2206","volume":"17","author":"CS Ritter","year":"2002","unstructured":"Ritter CS, et al. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res. 2002;17(12):2206\u201313.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1928_CR10","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1523-1755.2000.00370.x","volume":"58","author":"S Yano","year":"2000","unstructured":"Yano S, et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int. 2000;58(5):1980\u20136.","journal-title":"Kidney Int"},{"issue":"5","key":"1928_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","volume":"60","author":"CS Ritter","year":"2001","unstructured":"Ritter CS, et al. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int. 2001;60(5):1737\u201344.","journal-title":"Kidney Int"},{"issue":"3","key":"1928_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","volume":"52","author":"S Corbetta","year":"2000","unstructured":"Corbetta S, et al. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia. Clin Endocrinol (Oxf). 2000;52(3):339\u201348.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6318","key":"1928_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/350512a0","volume":"350","author":"T Motokura","year":"1991","unstructured":"Motokura T, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350(6318):512\u20135.","journal-title":"Nature"},{"issue":"1","key":"1928_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00223-011-9490-4","volume":"89","author":"Y Imanishi","year":"2011","unstructured":"Imanishi Y, et al. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism. Calcif Tissue Int. 2011;89(1):29\u201335.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1928_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jbmr.3674","volume":"34","author":"N Balenga","year":"2019","unstructured":"Balenga N, et al. Parathyroid-targeted overexpression of regulator of G-protein signaling 5 (RGS5) causes hyperparathyroidism in transgenic mice. J Bone Miner Res. 2019;34(5):955\u201363.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1928_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1359\/jbmr.090211","volume":"24","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, et al. Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res. 2009;24(7):1173\u20139.","journal-title":"J Bone Miner Res"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-01928-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-023-01928-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-01928-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T08:20:28Z","timestamp":1675844428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-023-01928-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1186\/s12893-023-01928-5","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by China Japan Friendship Hospital ethics committee. All methods were carried out in accordance with declaration of Helsinki. Informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}